1. Balali-Mood M, Hefazi M, Mahmoudi M, Jalali E, Attaran D, Maleki M, et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 2005; 19:713-721.
2. Hefazi M, Attaran D, Mahmoudi M, Balali-Mood M. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 2005; 17:587-592.
3. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. J Occup Environ Med 2003; 45:1136-1143.
4. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography Eur J Radiol 2004; 52:164-169
5. Ghanei M, Fathi H, Mohammad MM, Aslani J, Nematizadeh F. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 2004; 16:491-495.
6. Ghanei M, Khalili AR, Arab MJ, Mojtahedzadeh M, Aslani J, Lessan-Pezeshki M, et al. Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin Pharmacol Toxicol 2005; 97:302-305.
7. Mirsadraee M, Attaran D, Boskabady MH, Towhidi M. Airway hyper responsiveness to methacholine in chemical warfare victims. Respiration 2005; 72:523-528.
8. American Thoracic Society. Standardization of spirometry: 1994 Update. Official Statement of American Thoracic Society. Am J Respir Crit Car Med 1995; 152:1107-1136.
9. American Thoracic Society. Lung Function Testing: Selection of Reference Values and Interpretative Strategies. Am Rev Respir Dis 1991; 144:1202–1218.
10. Clark T, Busse W, Bousquet J, Holgate ST, Lenfant C, O Byrne P, et al. Global Initiative for asthma. Pocket guide for asthma management and prevention. Naional Institude of Health National Heart, Lung and blood Institude; publication 96-3659B 20021-29.
11. Simpson JL,Timmins NL, Fakes K, Talbot PI, Gibson PG. Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels. Eur Respir J 2004; 23 759–762.
12. Backman KS, Greenberger PA, Patterson R. Airway obstruction in pattern with long term asthma consistent with "Irreversible asthma". Chest 1997; 112:1234:1240.
13. Yilmaz S, Ekici A, Ekici M, Keles H. High-resolution computed tomography findings in elderly patients with asthma. Eur J Radiol 2006; 59:238-243.
14. Little SA, Sproule MW, Cowan MD, Macleod KJ, Robertson M, Love JG, et al. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax 2002; 57:247-253.
15. Bizeto L, Mazolini AB, Riberio M, Stelmac R, Cukier A, Nunes MPT. Interrelationship between serum and sputum inflammatory mediators in chronic obstructive pulmonary disease. Braz J Med Biol Res 2008; 41:193-198.
16. Birring SS, Parker D, McKenna S, Hargadons B, Brightling CE, Pavrod ID, et al. Sputum eosinophilia in idiopathic pulmonary fibrosis. Inflamm Res 2005; 54:51-56.
17. Vanaudenaerde BM, Meyts I, Vos R, Geudens N, De Wever W, Verbeken EK, et al. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 2008; 32:832-843.
18. Verleden GM. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment. Monaldi Arch Chest Dis 2000; 55:140-145.